funny, but patients in early px 866 trial showed stable living indicating that the trickery that cancer performs may have been slowed. That may be a "big deal" someday to people fighting the scurge if the right combo is found . A big deal - kind of like the way our great VP joe biden said it.
I accept the criticism about highly paid mangement but remember the company is lean and they have not one but SIX on going clinical trials happening in our time. In addition to being responsible for production on Px 866 and ONT 10 they are responsible for the doings of all those trials. While lean, that takes a good people that don't come cheap.
I will not defend a position in the stock of no name but I'm here in my desert camp nonetheless and speaketh truth as I see it.